ChristopherLeeDeCotiisMD

Pulmonology • Summit, NJ

Critical Care Medicine, Pleural Disease

Pulmonary/Critical Care

Join to view full profile

Dr. DeCotiis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. DeCotiis' full profile

Already have an account?

Office
1 Springfield Avenue
Third Floor
Summit, NJ 07901

Education & Training

NYU Grossman School of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2011 - 2014
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2008 - 2011
Rutgers New Jersey Medical SchoolClass of 2008

Certifications & Licensure

CA State Medical License 2015 - Present
NJ State Medical License 2016 - 2025
NY State Medical License 2011 - 2016
DC State Medical License 2008 - 2011
VA State Medical License 2008 - 2011
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

9 citations
Current readings: blood-based biomarkers for lung cancer.
Jun-Chieh J. Tsay, Christopher DeCotiis, Alissa K. Greenberg, William N. Rom
Seminars in Thoracic and Cardiovascular Surgery. 2013-12-01
17 citations
Inflammatory cytokines and non-small cell lung cancer in a CT-scan screening cohort: Background review of the literature.
Christopher DeCotiis, Yingjie Hu, Alissa K. Greenberg, Maryann L. Huie, Jun-Chieh J. Tsay
Cancer Biomarkers. 2016-01-01
Persistent air leak secondary to pneumothorax in COVID-19: A case report and review of literature.
Hanine Atwi, Christian von Gizycki, Syed Ahmad, Christopher DeCotiis
Respiratory Medicine Case Reports. 2024-01-01

Press Mentions

Helping Patients Breathe Easier, Atlantic Health System Offers Breakthrough Respiratory TreatmentSeptember 5th, 2024